Observational analysis reveals early metabolic risk in neonates of mothers with gestational diabetes, suggesting the need for monitoring metabolic biomarkers.
Objective To investigate early metabolic biomarkers in neonates born to mothers with gestational diabetes mellitus (GDM), focusing on amino acid and acylcarnitine profiles to assess metabolic risk, including obesity and future metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Demırel et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: